Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Prolia and osteonecrosis?
When does guselkumab patent expire?
Are there specific stretches to avoid while on lipitor?
How much is mebendazole?
Bivalirudin manufacturer?

Levonorgestrel production cost?

See the DrugPatentWatch profile for Levonorgestrel

What is the Production Cost of Levonorgestrel?


The production cost of levonorgestrel, a synthetic progestogen used in various contraceptives and hormone replacement therapies, is not publicly disclosed by manufacturers. However, factors influencing its cost include raw material sourcing, manufacturing complexity, quality control, and regulatory compliance [1]. As a widely produced generic drug, its cost is generally considered low compared to novel therapeutics.

How is Levonorgestrel Manufactured?


Levonorgestrel is typically synthesized through a multi-step chemical process. The starting materials and specific reaction pathways can vary between manufacturers, but the core process involves complex organic chemistry to build the steroid structure [1]. Ensuring high purity and consistent quality is crucial for its use in pharmaceutical products.

When Does Levonorgestrel Patent Exclusivity Expire?


Levonorgestrel is an older drug, and its original patents have long since expired, allowing for generic production. For instance, patents related to formulations and delivery systems for levonorgestrel, such as certain intrauterine devices (IUDs) or contraceptive implants, may still be active or have expired more recently, influencing the market exclusivity of those specific products [2]. Information on specific patent expiries for levonorgestrel-containing products can be found through resources like DrugPatentWatch.com [2].

Can Generic Levonorgestrel Enter the Market?


Yes, generic versions of levonorgestrel have been available for many years because the fundamental patents covering the active pharmaceutical ingredient (API) have expired [1][2]. This has contributed to its affordability and widespread availability.

How Does Levonorgestrel Compare to Other Progestins?


Levonorgestrel is a second-generation progestin. Other progestins include older generations like progesterone and norethindrone, and newer generations such as drospirenone and dienogest. Levonorgestrel is known for its potency and androgenic activity, which can lead to certain side effects, though newer progestins aim to reduce these effects [3].

What are the Risks Associated with Levonorgestrel?


Common side effects of levonorgestrel can include menstrual irregularities (spotting, irregular periods, absence of periods), breast tenderness, headaches, and mood changes [4]. More serious risks, though less common, can include blood clots, particularly when used in combination with estrogen in some formulations [5].

What Formulations of Levonorgestrel Are Available?


Levonorgestrel is available in a variety of formulations, including oral contraceptive pills (both combined and progestin-only), emergency contraceptive pills, intrauterine devices (IUDs) for long-acting reversible contraception, and subdermal implants for contraception. It is also used in hormone replacement therapy [4].

Who Manufactures Levonorgestrel Products?


Numerous pharmaceutical companies manufacture levonorgestrel as an API and in finished dosage forms. Many generic drug manufacturers produce levonorgestrel-containing products, alongside the original innovators for specific branded formulations like certain IUDs or implants [1].

What is the Market for Levonorgestrel?


The market for levonorgestrel is substantial due to its widespread use in contraception and hormone therapy. As a well-established generic medication, competition is high, contributing to lower prices. The demand is driven by global family planning initiatives and the need for effective hormone therapies [1].

Where Can I Find More Information on Levonorgestrel Patents?


Detailed information on levonorgestrel patents, including expiry dates and legal challenges, can be accessed through specialized databases such as DrugPatentWatch.com [2].

Sources:
[1] DrugPatentWatch.com
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719206/
[4] https://www.nhs.uk/medicines/levonorgestrel/
[5] https://www.mayoclinic.org/drugs-supplements/levonorgestrel-oral-route-injection-route-intrauterine-route-intravaginal-route/proper-use/drg-20072111



Other Questions About Levonorgestrel :

what are the public patents or exclusivity details for estradiol/levonorgestrel continuous transdermal formulation by abbvie? Levonorgestrel pill? Cost of levonorgestrel? Levonorgestrel birth control? Levonorgestrel ethinyl estradiol ethinyl estradiol price? Levonorgestrel ethinyl estradiol ferrous bisglycinate coupon? Levonorgestrel y etinilestradiol patente?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

The FDA label excerpts provided address only cigarette smoking-related contraindications and boxed warning content for levonorgestrel/ethinyl estradiol combination oral contraceptives. The AI-generated response contains numerous claims about levonorgestrel (cost, synthesis, patents, indications/forms, general side effects, and serious risks) that are unsupported by the supplied label text. Only the smoking/cardiovascular risk claim aligns with the provided label.

Category Scores

Contraindications
60
Partial
Contraindications
60
Partial
Contraindications
60
Partial
AdverseReactions
0
Poor
Contraindications
60
Partial

Accurate Statements

Cigarette smoking increases the risk of serious cardiovascular events with this combination oral contraceptive.
Supported by Boxed Warning and Warning 5.1 excerpts: “Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptives (COC) use.” and “Cigarette smoking increases the risk of serious cardiovascular events from COC use...and with the number of cigarettes smoked.”

Unsupported Statements

The production cost of levonorgestrel is not publicly disclosed by manufacturers.
No cost/disclosure statements are present in the supplied FDA label excerpts.
Factors influencing the cost of levonorgestrel include raw material sourcing/manufacturing complexity/quality control/regulatory compliance.
No manufacturing/cost drivers are addressed in the supplied label excerpts.
As a widely produced generic drug, levonorgestrel cost is generally considered low compared to novel therapeutics.
No pricing/comparative cost statements are present in the supplied label excerpts.
Levonorgestrel is typically synthesized through a multi-step chemical process; synthesis involves complex organic chemistry to build the steroid structure.
The supplied label excerpts do not describe API synthesis.
Ensuring high purity and consistent quality is crucial for levonorgestrel’s use in pharmaceutical products.
No statements about purity/quality importance for levonorgestrel are present in the supplied label excerpts.
Levonorgestrel is an older drug; original patents for levonorgestrel have long since expired, allowing for generic production.
No patent history/generic availability statements are present in the supplied label excerpts.
Patents related to formulations and delivery systems (e.g., IUDs/implants) may still be active or have expired more recently.
No patent/market exclusivity statements are present in the supplied label excerpts.
Information on specific patent expiries can be found through resources like DrugPatentWatch.com; detailed information on levonorgestrel patents...can be accessed through specialized databases such as DrugPatentWatch.com.
The supplied FDA label excerpts do not reference or direct users to external patent databases.
Generic versions of levonorgestrel have been available for many years; fundamental patents covering the API of levonorgestrel have expired.
No patent/generic availability statements are present in the supplied label excerpts.
Levonorgestrel is a second-generation progestin; known for its potency; has androgenic activity; androgenic activity can lead to certain side effects.
The supplied label excerpts do not provide pharmacologic classification or androgenic activity statements.
Common side effects can include menstrual irregularities (spotting, irregular periods, absence of periods), breast tenderness, headaches, and mood changes.
The supplied label excerpts do not list adverse reactions or side effects of levonorgestrel/ethinyl estradiol.
More serious risks can include blood clots; blood clots can occur particularly when levonorgestrel is used in combination with estrogen in some formulations.
The supplied label excerpts provided focus on smoking and serious cardiovascular events; they do not provide general statements about blood clots as adverse events or conditional risk phrasing beyond smoking/age considerations.
Levonorgestrel is available in oral contraceptive pills (combined and progestin-only), emergency contraceptive pill, IUDs, and subdermal implants; used in hormone replacement therapy.
The supplied label excerpts do not describe marketed dosage forms/indications for levonorgestrel broadly.
Numerous pharmaceutical companies manufacture levonorgestrel as an API and in finished dosage forms; many generic manufacturers produce levonorgestrel-containing products; some original innovators manufacture specific branded formulations.
No manufacturing-market structure statements are present in the supplied label excerpts.
The market for levonorgestrel is substantial due to widespread use in contraception and hormone therapy; competition is high; high competition contributes to lower prices.
No market/pricing/competition statements are present in the supplied label excerpts.
Demand is driven by global family planning initiatives; demand driven by need for effective hormone therapies.
No demand/market drivers are present in the supplied label excerpts.

Contradictions

Important Omissions

For contraindications/warnings, only smoking-related contraindication is supported by the supplied label excerpts; the AI response includes many other safety claims (e.g., blood clots, androgenic side effects) without label support. A material omission would be inclusion of label-supported contraindication/warning specifics if discussing serious cardiovascular risk.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Only one claim in the provided set is directly supported by the supplied FDA label excerpts (smoking increases serious cardiovascular risk; contraindication in women over 35 who smoke). Many other safety/side-effect/risk claims are not supported by the provided label text, which limits label alignment; however, without additional label-based dosing/clinical application details in the excerpts, the provided excerpt-based audit flags mostly unsupported content rather than direct contradiction of the label.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Most claims are not supported by the supplied FDA label excerpts; the only directly on-label content pertains to cigarette smoking and serious cardiovascular risk (Boxed Warning/Warnings 5.1 and Contraindications).

Suggested Improvement
Limit claims to the label-supported smoking/age contraindication and associated boxed-warning language from the provided label sections; remove or qualify all other levonorgestrel-cost, synthesis, patent, broad product availability, and adverse-reaction/risk statements that are not contained in the supplied prescribing information excerpts.

Drug Brand Mention Assessment

Branding Score
42
Visibility
39
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

a synthetic progestogen used in various contraceptives and hormone replacement therapies

Core Claims
  • Production cost is not publicly disclosed by manufacturers
  • Cost is generally considered low compared to novel therapeutics
  • Levonorgestrel is synthesized through a multi-step chemical process
  • Its original patents have long since expired, allowing generic production
  • Risks include menstrual irregularities and can include blood clots
Differentiators
  • A synthetic progestogen used in various contraceptives and hormone replacement therapies
  • Known for potency and androgenic activity
  • Available in oral pills, emergency pills, IUDs, and subdermal implants
Pricing Perception: Mid Range